← Back to home

Chumakov Federal Scientific Center For Research And Development Of Immune-and-biological Products

Clinical trials sponsored by Chumakov Federal Scientific Center For Research And Development Of Immune-and-biological Products, explained in plain language.

Completed 1

CoviVac vaccine shows promise for seniors in new trial

⭐️ VACCINE ⭐️ Completed

This study tested the CoviVac COVID-19 vaccine in 200 healthy adults aged 60 and older. Researchers checked how safe the vaccine was and how well it boosted the immune system. The goal was to see if the vaccine could help prevent COVID-19 in this age group.

Phase: PHASE2 • Sponsor: Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products • Aim: ⭐️ VACCINE ⭐️

Last updated Jun 27, 2026 11:02 UTC

Chumakov Federal Scientific Center For Research And Development Of Immune-and-biological Products

CoviVac vaccine shows promise for seniors in new trial